β-amyloid (Aβ) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease

被引：67

作者：

Andreasen, N ^{[1
]}

Blennow, K

机构：

[1] Huddinge Univ Hosp, Karolinska Inst, Neurotec, Dept Geriatr Med, SE-14186 Stockholm, Sweden

[2] Univ Gothenburg, Dept Clin Neurosci, Unit Neurochem, Gothenburg, Sweden

[3] MRC, Stockholm, Sweden

来源：

PEPTIDES | 2002年 / 23卷 / 07期

关键词：

Alzheimer's disease (AD); beta-amyloid (A beta); biochemical markers; cerebrospinal fluid (CSF); plasma; diagnosis;

D O I：

10.1016/S0196-9781(02)00056-6

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

With the arrival of symptomatic treatment (acetylcholine esterase inhibitors) and the promise of drugs that may delay disease progression, development of diagnostic biomarkers for Alzheimer's disease (AD) are important. beta-Amyloid (Abeta) protein is the main component of senile plaques. A marked reduction in cerebrospinal nuid (CSF)-Abeta42 in AD has been found in numerous studies. Importantly, reduced CSF-Abeta42 is also found very early in the disease process, before the onset of clinical symptoms. Recent studies suggest that CSF-Abeta42 have a satisfactory performance when used as a diagnostic marker for AD in clinical routine. This paper reviews CSF-Abeta42 as a biomarker for AD. (C) 2002 Elsevier Science Inc. All rights reserved.

引用

页码：1205 / 1214

页数：10

共 100 条

[21] AMYLOID BETA-PEPTIDE IS PRODUCED BY CULTURED-CELLS DURING NORMAL METABOLISM [J].

HAASS, C ;

SCHLOSSMACHER, MG ;

HUNG, AY ;

VIGOPELFREY, C ;

MELLON, A ;

OSTASZEWSKI, BL ;

LIEBERBURG, I ;

KOO, EH ;

SCHENK, D ;

TEPLOW, DB ;

SELKOE, DJ .

NATURE, 1992, 359 (6393) :322-325

[22] AMYLOID DEPOSITION AS THE CENTRAL EVENT IN THE ETIOLOGY OF ALZHEIMERS-DISEASE [J].

HARDY, J ;

ALLSOP, D .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (10) :383-388

[23] PRESENILE-DEMENTIA AND CEREBRAL-HEMORRHAGE LINKED TO A MUTATION AT CODON-692 OF THE BETA-AMYLOID PRECURSOR PROTEIN GENE [J].

HENDRIKS, L ;

VANDUIJN, CM ;

CRAS, P ;

CRUTS, M ;

VANHUL, W ;

VANHARSKAMP, F ;

WARREN, A ;

MCINNIS, MG ;

ANTONARAKIS, SE ;

MARTIN, JJ ;

HOFMAN, A ;

VAN BROECKHOVEN, C .

NATURE GENETICS, 1992, 1 (03) :218-221

[24]

Hesse Camilla, 2000, Journal of Alzheimer's Disease, V2, P199

[25] AGGREGATION AND SECONDARY STRUCTURE OF SYNTHETIC AMYLOID BETA-A4 PEPTIDES OF ALZHEIMERS-DISEASE [J].

HILBICH, C ;

KISTERSWOIKE, B ;

REED, J ;

MASTERS, CL ;

BEYREUTHER, K .

JOURNAL OF MOLECULAR BIOLOGY, 1991, 218 (01) :149-163

[26] Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF [J].

Hulstaert, F ;

Blennow, K ;

Ivanoiu, A ;

Schoonderwaldt, HC ;

Riemenschneider, M ;

De Deyn, PP ;

Bancher, C ;

Cras, P ;

Wiltfang, J ;

Mehta, PD ;

Iqbal, K ;

Pottel, H ;

Vanmechelen, E ;

Vanderstichele, H .

NEUROLOGY, 1999, 52 (08) :1555-1562

[27] Analysis of heterogeneous beta A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay [J].

Ida, N ;

Hartmann, T ;

Pantel, J ;

Schroder, J ;

Zerfass, R ;

Forstl, H ;

Sandbrink, R ;

Masters, CL ;

Beyreuther, K .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (37) :22908-22914

[28] VISUALIZATION OF A-BETA-42(43) AND A-BETA-40 IN SENILE PLAQUES WITH END-SPECIFIC A-BETA MONOCLONALS - EVIDENCE THAT AN INITIALLY DEPOSITED SPECIES IS A-BETA-42(43) [J].

IWATSUBO, T ;

ODAKA, A ;

SUZUKI, N ;

MIZUSAWA, H ;

NUKINA, N ;

IHARA, Y .

NEURON, 1994, 13 (01) :45-53

[29] THE CARBOXY TERMINUS OF THE BETA-AMYLOID PROTEIN IS CRITICAL FOR THE SEEDING OF AMYLOID FORMATION - IMPLICATIONS FOR THE PATHOGENESIS OF ALZHEIMERS-DISEASE [J].

JARRETT, JT ;

BERGER, EP ;

LANSBURY, PT .

BIOCHEMISTRY, 1993, 32 (18) :4693-4697

[30] Diagnostic accuracy of Alzheimer's disease: A clinicopathological study [J].

Jellinger, KA .

ACTA NEUROPATHOLOGICA, 1996, 91 (02) :219-220

← 1 2 3 4 5 6 7 8 9 10 →